Literature DB >> 7877516

Intentions to use hormone replacement therapy in a community sample of 45-year-old women.

M S Hunter1, K L Liao.   

Abstract

A sample of 45-year-old women from 5 general practices in South London were asked about their intentions to use hormone replacement therapy by postal questionnaire. One hundred and six women (60%) responded. Ninety women who were not taking HRT formed the study sample. Over 80% expressed an opinion when asked about future HRT use. Forty-four percent expressed an intention to use HRT, 42% expressed an intention not to, and 13% expressed a lack of knowledge on which to base a decision. Reasons given by intenders were based on general hopes to 'feel better' among others. Non-intenders gave reasons reflecting disinclination to use drugs and to interfere with a normal process, as well as concerns about side-effects. The characteristics of intenders and non-intenders were compared. There were no significant differences between groups in socio-demographic variables, or in general and gynaecological health factors. However, HRT intenders reported significantly lower self-esteem, higher levels of depressed mood, anxiety, and negative attitudes to the menopause. They also expressed stronger beliefs in their doctors' ability-as opposed to their own- to control their menopause experience. These results suggest that some women might be seeking HRT at menopause to help alleviate pre-existing emotional difficulties and this may have important implications for treatment adherence.

Entities:  

Mesh:

Year:  1994        PMID: 7877516     DOI: 10.1016/0378-5122(94)90096-5

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  4 in total

1.  Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study.

Authors:  A J Welton; M R Vickers; J A Cooper; T W Meade; T M Marteau
Journal:  BMJ       Date:  1999-04-24

2.  Usage patterns of over-the-counter phenazopyridine (pyridium).

Authors:  Chih-Wen Shi; Steven M Asch; Eve Fielder; Lillian Gelberg; Robert H Brook; Barbara Leake; Martin F Shapiro; Patrick Dowling; Michael Nichol
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

3.  Factors associated with the difference in score between women's and doctors' decisional conflict about hormone therapy: a multilevel regression analysis.

Authors:  France Légaré; Stéphane Tremblay; Annette M O'Connor; Ian D Graham; Georges A Wells; Mary Jane Jacobsen
Journal:  Health Expect       Date:  2003-09       Impact factor: 3.377

4.  [Factors influencing the adoption of hormone replacement therapy].

Authors:  F Légaré; S Dodin; G Godin
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.